Results 11 to 20 of about 1,446 (206)

Dopamine genetic risk score predicts impulse control behaviors in Parkinson’s disease

open access: yesClinical Parkinsonism & Related Disorders, 2021
Introduction: Up to 40% of Parkinson’s disease patients taking dopamine agonist medication develop impulse control behaviors which can have severe negative consequences.
Alison Hall   +5 more
doaj   +1 more source

Infusion of D1 dopamine receptor agonist into medial frontal cortex disrupts neural correlates of interval timing

open access: yesFrontiers in Behavioral Neuroscience, 2015
Medial frontal cortical (MFC) dopamine is essential for the organization of behavior in time. Our prior work indicates that blocking D1 dopamine receptors (D1DR) attenuates temporal processing and low-frequency oscillations by MFC neuronal networks ...
Krystal L Parker   +2 more
doaj   +1 more source

A Role for Adenosine A1 Receptors in GABA and NMDA-Receptor Mediated Modulation of Dopamine Release: Studies Using Fast Cyclic Voltammetry

open access: yesSensors, 2008
In the striatum many neurotransmitters including GABA, glutamate, acetylcholine, dopamine, nitric oxide and adenosine interact to regulate synaptic transmission. Dopamine release in the striatum is regulated by a number of pre- and postsynaptic receptors
Carmel O’Neill   +1 more
doaj   +1 more source

Clinical guidelines ‘Hyperprolactinemia’ (draft)

open access: yesОжирение и метаболизм, 2023
Hyperprolactinemia is a persistent excess of the blood serum prolactin. The syndrome contains various symptoms, the most characteristic is a violation of the reproductive system.
I. I. Dedov   +15 more
doaj   +1 more source

Dopamine agonists and antipsychotics [PDF]

open access: yesEuropean Journal of Endocrinology, 2020
There can potentially be a number of clinical interactions that could adversely affect patient outcomes in a patient with a prolactinoma and psychiatric disease that might require antipsychotic and dopamine agonist treatment. Dopamine agonists stimulate the dopamine D2 receptor, resulting in a decrease in prolactin (PRL) levels and in prolactinoma size
openaire   +2 more sources

Aripiprazole-induced hyperprolactinemia in a young female with delusional disorder

open access: yesIndian Journal of Psychological Medicine, 2016
Hyperprolactinemia is a common adverse effect of antipsychotic medication. Switching over to aripiprazole or adjunctive aripiprazole has been advocated for optimal management of antipsychotic-induced hyperprolactinemia.
Sam Padamadan Joseph
doaj   +1 more source

Irreversible extreme freezing of gait after dopamine agonist withdrawal

open access: yesClinical Case Reports, 2021
Dopamine agonist withdrawal can cause freezing of gait in PD patients.
Mehri Salari   +4 more
doaj   +1 more source

Mechanisms Underlying Dopaminergic Regulation of Nicotine-Induced Kinetic Tremor

open access: yesFrontiers in Pharmacology, 2022
Nicotine induces kinetic tremor, which resembles pharmacological features of essential tremors, via activating the inferior olive (IO) neurons. Since nicotine is known to enhance dopamine release by stimulating α4β2 and/or α6 nACh receptors, we examined ...
Masaki Kato   +4 more
doaj   +1 more source

Enhancement in dopamine reduces generous behaviour in women.

open access: yesPLoS ONE, 2019
Generosity is a human behavior common in social contexts. However, humans are not equally generous to everyone alike. Instead, generosity decreases as a function of social distance, an effect called social discounting.
Sergio Oroz Artigas   +6 more
doaj   +1 more source

In a Rush to Decide: Deep Brain Stimulation and Dopamine Agonist Therapy in Parkinson's Disease

open access: yesJournal of Parkinson’s Disease, 2014
Background: It has been suggested that all patients with Parkinson's disease (PD) who undergo functional neurosurgery have difficulties in slowing down in high conflict tasks.
Atbin Djamshidian   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy